The Food and Drug Administration (FDA) has cleared the FreeStyle ® Libre 2 iOS App for use with the FreeStyle Libre 2 14-day glucose sensors in individuals 4 years of age and older with diabetes. The ...
Some users in the UK are experiencing a disruption in the functionality of the FreeStyle Libre 2 blood sugar monitoring app following an update, and it underscores the vulnerability of our digital ...
More than a year after getting the FDA nod for its CGM FreeStyle Libre 2, Abbott landed FDA clearance for the system’s iOS companion app. This new designation allows FreeStyle Libre 2 users to access ...
The Abbott FreeStyle Libre 2 can be used as a real-time continuous glucose monitor (CGM) with an upgrade to the FreeStyle LibreLink app. Please note, the below information comes with a critical update ...
MISSISSAUGA, Ontario, Oct. 4, 2018 /CNW/ -- Abbott (NYSE: ABT) announced today the company has received the Health Canada license of its FreeStyle LibreLink mobile app for use with compatible iOS ...
"The best healthcare solution is the one that helps the most people, which is why we designed our FreeStyle Libre portfolio with access and affordability in mind from the very beginning," said ...
The theme of World Diabetes Day is ‘Wellbeing’ this year, so we wanted to present a new approach to diabetes management that puts your wellbeing first. As a member, you’ll gain access to Gro Health’s ...
Abbott Laboratories ABT recently announced the receipt of the FDA’s approval for its next-generation FreeStyle Libre 2 integrated continuous glucose monitoring (“iCGM”) system for use in diabetic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback